MX2012011796A - Guerbet alcohol alkoxylate surfactants and their use in enhanced oil recovery applications. - Google Patents
Guerbet alcohol alkoxylate surfactants and their use in enhanced oil recovery applications.Info
- Publication number
- MX2012011796A MX2012011796A MX2012011796A MX2012011796A MX2012011796A MX 2012011796 A MX2012011796 A MX 2012011796A MX 2012011796 A MX2012011796 A MX 2012011796A MX 2012011796 A MX2012011796 A MX 2012011796A MX 2012011796 A MX2012011796 A MX 2012011796A
- Authority
- MX
- Mexico
- Prior art keywords
- marker
- implanted
- medical device
- signal
- attribute
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 2
- 238000011084 recovery Methods 0.000 title abstract 2
- 239000004094 surface-active agent Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000003550 marker Substances 0.000 claims description 42
- 238000001514 detection method Methods 0.000 claims description 34
- 230000005855 radiation Effects 0.000 claims description 17
- 230000005670 electromagnetic radiation Effects 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 8
- 238000002513 implantation Methods 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 230000001012 protector Effects 0.000 claims description 4
- 238000007920 subcutaneous administration Methods 0.000 claims description 4
- 238000002604 ultrasonography Methods 0.000 claims description 4
- 125000006850 spacer group Chemical group 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 125000000129 anionic group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 abstract 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 abstract 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- 239000003945 anionic surfactant Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000006471 dimerization reaction Methods 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 description 9
- 238000013461 design Methods 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/58—Compositions for enhanced recovery methods for obtaining hydrocarbons, i.e. for improving the mobility of the oil, e.g. displacing fluids
- C09K8/584—Compositions for enhanced recovery methods for obtaining hydrocarbons, i.e. for improving the mobility of the oil, e.g. displacing fluids characterised by the use of specific surfactants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
- C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
- C07C305/10—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
- C07C309/09—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton
- C07C309/10—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton with the oxygen atom of at least one of the etherified hydroxy groups further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
- C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
- C08G65/2606—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups
- C08G65/2609—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups containing aliphatic hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
- C08G65/3344—Polymers modified by chemical after-treatment with organic compounds containing sulfur containing oxygen in addition to sulfur
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH OR ROCK DRILLING; MINING
- E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
- E21B43/00—Methods or apparatus for obtaining oil, gas, water, soluble or meltable materials or a slurry of minerals from wells
- E21B43/16—Enhanced recovery methods for obtaining hydrocarbons
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Geology (AREA)
- Mining & Mineral Resources (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Environmental & Geological Engineering (AREA)
- Geochemistry & Mineralogy (AREA)
- Detergent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Cosmetics (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Compositions and methods of synthesis of anionic surfactants by alkoxylation of a Guerbet alcohol (GA) having 12 to 36 carbon atoms using butylene oxide, and optionally propylene oxide and/or ethylene oxide followed by the incorporation of a terminal anionic group are described herein. The GA of the present invention is made by a facile and inexpensive method that involves high temperature base catalyzed dimerization of alcohols with 6 to 18 carbon atoms. The large hydrophobe ether surfactants of the present invention find uses in enhanced oil recovery (EOR) applications where it is used for solubilization and mobilization of oil and for environmental cleanup. Further, the hydrophobe alkoxylated GA without anionic terminal group can be used as an ultra- high molecular weight non-ionic surfactant.
Description
SYSTEMS AND METHODS TO IDENTIFY AND LOCATE A DEVICE
IMPLANTED DESCRIPTION OF THE INVENTION
The briefly summarized embodiments of the present invention are directed to a system for identifying an attribute of an implanted medical device, such as a port or access device. Information about the device, such as type, size, location, power injectability, etc., can be ensured, thereby increasing the success of the device, the convenience of the user, and the safety of the patient.
In one modality,. the identification system comprises a marker included with the implanted medical device, wherein the marker is related to an attribute-of the device; implanted doctor. An external detection device is also included to externally detect the implanted device. The detection device includes a signal source that emits an incident electromagnetic signal to collide on the marking of the implanted medical device, a detector that detects a signal of return of the marking resulting from the collision of the incident electromagnetic signal, and an interface of user to carry the information in relation to the attribute based on the detection of the return signal. In the case of an implantable access device, for example, the described system allows information, such as the ability of the device to withstand injection of fluid power therethrough, to be ensured after the device has been implanted. Subcutaneous form within the patient.
These and other features of the embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by practicing the embodiments of the invention as set forth thereafter.
BRIEF DESCRIPTION OF THE DRAWINGS
A more particular description of the present narrative will be presented by reference to specific embodiments thereof that are illustrated in the accompanying drawings. It is appreciated that these drawings represent only typical embodiments of the invention and will therefore not be considered as limiting their scope. Exemplary embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
FIGURE 1 is a perspective view of an access device and catheter including a plurality of markers, according to one embodiment;
FIGURE 2 is a partial cross-sectional side view of an implanted access device and identification system according to one embodiment;
FIGURE 3A is a top view of an access device including a plurality of markers according to one embodiment;
FIGURE 3B is a side view of the access device of FIGURE 3A;
FIGURE 4A is a partial cross-sectional perspective view of an implanted access device and identification system according to one embodiment;
FIGURE 4B is a side view of a device display portion, of identification shown in FIGURE 4A;
FIGURE 5 is a perspective view of an identification device including a light shield according to one embodiment; - · '
FIGURE 6 is a perspective view of the light shield of FIGURE 5;
FIGURE 7 is a perspective view of an identification device according to one embodiment;
FIGURE 8 is a perspective view of an identification device according to one embodiment;
FIGURES 9A and 9B are various views of an access device and representative images as represented by the identification device according to one embodiment;
FIGS. 10A-10C show several examples of markers for an access device according to one embodiment;
FIGURE 11 is a partial cross-sectional perspective view of an implanted access device and identification system according to one embodiment;
FIGURES 12A-12C show several views of a guide for needle and dressing according to one embodiment; Y
FIGURE 13 is a perspective view of a guide for needle and dressing according to one embodiment.
Now reference will be made to. the figures, where similar structures will be provided with similar reference designations. It will be understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention; and they are not limiting or necessarily drawn to scale.
For clarity, it will be understood that the word "next" refers to a direction relatively closer to a physician using the device that will be described herein, while the word "distal" refers to an address relatively further from the physician. For example, the end of a catheter placed within the body of a patient is considered a distal end of the catheter, while the end of the catheter that is outside the body is a proximal end of the catheter. Also, the words "including", "has" and "having" as used herein, are included in the claims, will have the same meaning as the word "comprising".
Modes of the present invention are generally directed to a system for identifying and / or locating an implanted medical device, such as an access device, and for facilitating access to such a device. In particular, the identification of an attribute of the medical device after implantation allows a physician to better utilize the device, thereby increasing the success of the device, the user's convenience and the safety of the patient. In addition, and as mentioned, the system can help locate and access the implanted device, such as access; to an access device with a water, for example. - It is appreciated that, through the use of the systems and components described herein, approaches on the identification of and access to an implanted access device, other types of implanted devices, including medical devices, can benefit from the principles and embodiments described herein.
First reference is made to FIGURES 1 and 2, which represent various details of an implantable access device 20 and a related system, generally designated at 10, to identify and / or characterize the access device or other implanted medical device, in accordance with one modality. As shown, the access device 20 includes a body 14 defining a fluid cavity that is covered by a membrane 16. A rod 18 extends from the device body 14 and serves as an outlet for the fluid cavity. As shown in FIGURE 2, the rod 18 is configured to operatively connect to a catheter 20 to provide fluid communication between the catheter and the fluid quality of the device. Note that catheter 20 is representative only of a wide variety of catheters, including PICCs, central catheters, etc., which may be employed. Also, although 'it is. described herein primarily as an access device, the medical device of the embodiments discussed herein may optionally include any number of devices subcutaneously, implantable in a body of a patient. The modalities that will be described therefore should not be limited in this way.
According to one embodiment, one or more markers 24 are included in a portion of the catheter 20 as part of the identification system 10. Each marker 24 is configured to be visible when the image is captured by the ultrasound device after implantation of the access device 12 under the skin 28 of the patient (FIGURE 2). As shown in FIGURES 1 and 2, markers 24 can be arranged in a specific pattern, such as a "bar code" format, which can provide information regarding one or more attributes of the access device to which it is connected operatively the catheter 20, as in FIGURE 2. For example, markers 24 may relate to a modality to the capacity from the access device to support a relatively high fluid flow rate. through it, also referred to herein as "energy injection". In one embodiment, for example, the energy injection fluid flow rates include a flow of about 5 ml per second at a pressure of about 21,092 kg / cm (300 psi), although other flow rates and pressures are also possible. In addition, other attributes of the access device and / or catheter or other medical device may also be indicated by the markers 24, which include device size, type, fluid cavity capacity, implantation date, etc.
In one embodiment, the markers 24 include a material that varies in density and / or surface reflectivity of the catheter material to provide an ultrasensively detectable specimen. In another embodiment, markers 24 include an ultrasonically opaque, non-metallic, MRI-compatible dye in a translucent catheter, such as when the catheter is coated, extruded into the catheter, etc.
In another embodiment, it is appreciated that markers can be configured so that an image is captured or detected by another modality that is sufficiently transmissive through body tissue including optical fluorescence, RF (such as by electromagnetic radiation by UV or IR wavelength) , magnetic, etc. In one embodiment, for example, the markers may include a dark material such as tungsten, to provide a high dark / luminous contraction between the markers and the catheter, device, etc., so that the contrast is detected when illuminated by a Proper lighting source and captured in the image optically by a camera. -Also., Markers in a modality can be included in the same access device body.
The system 10 further includes detection devices, or external identification device 30 ("ID"), configured to detect markers 24 of implanted catheter 20 (or optionally, device 12) when the device is placed in sufficient proximity to the subcutaneous markers 24 while remaining external to the patient's body, such as by placing the ID device against the skin 28 of the patient. In the present embodiment, the ID device 30 includes an ultrasonic image capture device. As such, the ID device 30 includes an image capture head 34 that houses a transducer to emit ultrasonic signals and detect reflected signals. Note that the markers 24 in one mode are sufficiently separated from one another to allow the transducer to distinguish each of the markers according to the resolution of the transducer.
In particular, the ultrasonic signal emitted by the transducer of the image capture head 34 is configured to travel through the body tissue of the patient and collide on the markers 24 of the catheter 20. The ultrasonic signal is then reflected and, as a signal from return, it is detected with the reception by the transducer. The ID device 30 includes the circuitry and algorithms to allow the return signal to be processed and for the information with respect to the detection of the markers 40 to be transported to a user by a user interface, such as a screen 36 included on the ID device.
For example, in the embodiment shown in FIGURE 2, the screen 36 includes an image 36A that includes an "injectable energy" message, to indicate that the access device to which the catheter 20 including the markers 24 is connected, is capable of to withstand the pressures and proportions of fluid flow associated with the energy injection. In the case of markers 40 that form a detectable pattern, bar code, etc. the circuitry of the ID device and algorithms may include functionality to allow the detected pattern to be interpreted to allow the identification of the attribute indicated by the markers 24 to be transported to the user of the ID device 30 via the user interface. In another embodiment, the ID device only carries the presence, number, form, or other configuration of the markers themselves so that a user can interpret the markers and determine the attribute represented accordingly.
It is appreciated that other messages and / or identification information may be displayed on the screen 36 with respect to the attribute of the access device or other implanted medical device on which one or more markers 24 refer. In other modalities, it is also appreciated -which. other user-interface modalities - can be used, including audio elements, lights, etc .; to carry a user the ID and information device with respect to the detected markers. One or more control buttons 38 or other control interfaces are included to control the functionality of the ID device 30.
As mentioned in the above, markers of the access device or other implanted medical device may include other modalities instead of ultrasound. FIGS. 3A and 3B represent an example of this, wherein the access device 12 includes a plurality of markers 40 that are configured to react to the collision thereon of electromagnetic radiation of a predetermined wavelength. In particular, three markers 40 are placed on the body 14 of the access device in a triangular configuration on the membrane 16. Other numbers, sizes, positions, etc., of the markers can also be used with this or other types of implantable medical devices. . The markers 40 may be connected to or integrated with the device body 14 in any number of suitable ways, including deposition or adhesion of a marker material on the surface of the device, molding or insertion into a defined cavity in the device, etc. In one embodiment, all or a portion of the access device body itself can serve as a marker, wherein the body material includes material that allows it to produce a return signal, as further described below.
When arranged in an access device or other device that is implanted within the body of the patient, the markers 40 described in the above are configured to emit, reflect or fluoresce a return beam of electromagnetic radiation when it is struck by an external beam. incident of electromagnetic radiation directed through the skin and tissue of the patient towards the implanted device. For example, in one embodiment, the markers 40 in the implanted device 12 include a material that emits a return beam of infrared wavelength radiation when it strikes the incident beam of infrared electromagnetic radiation. The infrared radiation emitted from the markers 40 can be detected externally to the patient, thereby allowing the information with respect to one or more attributes of the device to be secured after the implantation of the device.
In another embodiment, other wavelengths of electromagnetic radiation may form the incident beam, such as ultraviolet ("UV") wavelength radiation, which results in a UV radiation return beam of the markers 40 and through the Patient's tissue for detection outside the patient's body. Note that the term "beam" is used in the present only to indicate a certain amount of radiation traveling in one or more general directions. In still other embodiments, other suitable wavelengths of radiation, including visible or radiofrequency ("rF") wavelengths may be employed. Also, in one embodiment, the markers may be configured such that, when the incident beam or radiation of a first wavelength strikes, they emit a return beam of radiation of a second distinct wavelength, such as IR for the incident beam. and UV for the return beam. In this case, a photo-excitable phosphor by IR to organic UV with adequate fluorescence can be used for the marker. Such a marker may need to be encapsulated to provide biocompatibility. More generally, other suitable matches can be employed in the described embodiments. In another embodiment, the radiation emitter can simultaneously or sequentially emit radiation over a spectrum of wavelengths and the return beam includes one or more emitted wavelengths. In still other embodiments, the marker may include an LED light connected to or integrated with the medical device, the LED light may be detected by an external detection device, when it is illuminated. These and other variations by. therefore they are contemplated.
FIGURES 4A and 4B show details of the ID device 30, configured here to detect an implanted device., such as device 12 including markers 40 as shown in FIGS. 3A and 3B, post-implantation. As shown, the ID device 30 in the present embodiment includes a signal source, such as an LED 44, for producing and emitting the incident beam of infrared electromagnetic radiation. The ID device 30 further includes a detector, such as a CCD camera 46 for detecting a radiation return beam received from the markers 40. The LED 44 and the camera 46 are arranged on a lower face of the ID device 30 or in another form to provide adequate transmission and reception of the radiation beams. Separators 48 are included with the ID device 30 in the present embodiment to provide adequate separation of the LED and camera from the skin 28 of the patient and the implanted device 12. In other embodiments, the separators may be adjustable or omitted from the ID device. In yet another embodiment, the beam produced by LED or other signal source can be focused.
As shown in FIGURE 4A, during the operation the ID device is placed against the patient's skin 28 near the location where the device is believed to be disposed subcutaneously. In the present modality, the separators. 48 of the ID device 30 are placed in contact with the skin 28, but in other embodiments, the ID device can be held only on the skin, without contacting it. An incident beam of infrared radiation is emitted by the LED 44 and is directed to travel through the body tissue for collision on the markers 40 included in the subcutaneous device 12. The impact of the incident beam on the markers 40 causes the markers to emit a return beam of infrared radiation that is transmitted through the body tissue and is detected by the camera 46 of the ID device 30. As in the above, the ID device 30 includes suitable circuitry and algorithms for interpreting the return beam and determining the attributes of the device 12 as indicated by the markers 40, such as the energy injectability of the device, for example.
In one embodiment, for example, detection by the infrared radiation return beam ID device 30 indicates that an implanted device deploys markers that produced the return beam is located under the device. The ID device 30 can then interpret the received return beam according to the data programmed, stored or otherwise received by the "device as to the attribute represented, by the device marker that produced the return beam. with respect to the device attribute then it can be represented on the screen 36 of the ID device 30, or otherwise taken to the user of the ID device FIGURE 4A provides an example of an image 36A depicted on the screen 36, which provides a stored representative image of the device and indicates that the device can be injected with power FIGURE 4B provides another example of the image 36A, where the representations of the markers 40 as detected according to a present position of the ID device 30 on the access device 12 are shown together with an indication of the device's power injectibility.
Therefore, it is appreciated that a wide variety of representations may be displayed by the system 10 to indicate a wide variety of attributes of the access device or other implanted medical device. In one embodiment, it is appreciated that the ID device can be used to identify different types of devices, for example, access devices vs. catheters, etc.
With respect to the incident beam of electromagnetic radiation, it is appreciated that the wavelength thereof can be tuned by the ID device to easily allow the identification of the return beam "of the markers of the device when it is received by the device and avoids possible confusion by other sources of radiation, approximate that may be present, and also note that the markers can be configured to emit a return beam of wavelength different from those of the incident beam, as already mentioned. both are contemplated.
FIGURES 5 and 6 show various details representing the ID device 30 according to one embodiment, wherein a light shield 50 including opposite open ends is included for obtaining a lower portion of the device. In this configured manner, the light shield 50 can act as a shield to prevent ambient light or other electromagnetic radiation from entering the volume within the tube, therallowing the camera 46, disposed within the dark part created by the light protector, be a low luminance camera. In such an embodiment, the light shield 50 is manufactured to be substantially non-transmitting of electromagnetic radiation that can interfere with the sensitivity of the camera 46. Such non-transmitting qualities can be achieved by a coating applied to the outer or inner surface of the shield, or when printing materials-transmitters in the material from which a light protector is formed.
As shown in FIGURE 5, in one embodiment, a plurality of LEDs 44 can be arranged on a lower perimeter of the ID device 30 so that the emitted beams of each LED are transferred to the patient's tissue mainly along the beam paths 52 through the longitudinal length of the light shield 50 itself when the ID device is connected. The light shield 50 may include acrylic or other suitable material, and may be removably or permanently connected to the ID device 30. Although it has a cylindrical shape here, the light shield can include one of several possible ways to accommodate the correlation with the ID device and the surface of the patient's skin.
FIGURE 7 shows another embodiment of the ID device 30, wherein a projector 54 is included in a lower face of the device to allow a representative projection of the detected access device 12 or other implanted device to deploy to the skin 28 the patient directly over the detected location of the device. In particular, the detection of the access device 12 is made by the use of an incident beam (produced by the LEDs 44 of the ID device 30) which hits the markers 40 of the device 12 and the subsequent reception of a return beam of the markers 40 as of course · by | 1-to chamber 46, as in previous modalities. This in turn allows an attribute of the device 12, i.e. its location under the skin 28, to be determined by the ID device 30, due to the ability of the ID device to determine the geometries of the incident beam, the return beam and the projected image path Once the location of the device is determined, the ID device 30 can project a projected image 58 representative of the access device, the markers, etc., onto the skin 28 over the the location of the implanted device, through the projector 54. This allows a physician who sees the projected image 58 to secure the location of the access device 12 and conveniently access the membrane 16 thereof (FIGURE 1) with a needle or other Such a projection may be employed in addition to or in lieu of the representation on an ID device screen.Projected image 58 may include one or more of various designs, words, images, etc. ., which include a representation of the markers actually detected by the camera 46 or an image stored in a memory location of the ID device 30 corresponding to the type of access device identified by the ID device according to the detected markers therefore.
FIGURE 8 shows another mode of the device
ID 30, wherein the ID device 30 is not an autonomous unit, but more -n-includes separate components. In detail, the device 30 of. ID includes a pocket 30A module containing a needle &Ckde guide, for containing a needle 62.r.a output for emitting a 'beam of electromagnetic radiation, a camera for detecting return signals from the markers, and the Projector 54 for projecting the image 58 of the device 12, once it is detected.
The ID device 30 further includes a component module 30B operatively connected to the pocket module 30A by a cable 30C. The component module 30B in the present embodiment includes a lighting system for transmitting electromagnetic radiation from the component module to the outlet in the pocket module by a suitable conduit in the 30C cable, and necessary circuitry and electronic modules to enable the functionality of the ID device. Such an ID device design provides a relatively small pocket device for use "in locating and identifying the implanted device, thereby providing improved convenience to the user.
FIGURES 9A and 9B show that a representative image of the implanted access device 12 can help determine the orientation of the post-implantation of the device. As shown in FIGURE 9A, when the device 12 is positioned within the body to be substantially parallel to the skin, the markers 40 thereof will be detected by the ID device with a desired orientation, or spacing, with respect to each other. The projector 54 ~ of the ID device can then project the image 58 representative of the markers 40 with the same orientation, thus indicating to the observer that the device is properly positioned.
If the device has rotated towards an oblique orientation within the body, as seen in FIGURE 9B, the ID device 30 will detect the markers 40 of the device with a different spacing and will display the projected image 58 as such, thereby indicating that the orientation of the device is oblique. A similar situation could be observed in the image 36A of the screen 36 of the device, if desired (FIGURES 4A, 4B).
FIGURES 10A-10C show examples of other possible configurations for positioning the markers 40 on the access device 12, which include placing more marker points on the device membrane 16, bands across the membrane, and a band around the perimeter of the membrane. These and other marker configurations are therefore possible, as appreciated by one of skill in the art. Note also that these marker configurations are representative of the placement on other implantable devices as well.
FIGURE 11 shows that in one embodiment, the marker can include an active or passive RFID chip 70, which can be detected by an "RFID reader component" included in the ID device 30. In this configured manner, extensive information regarding the attributes of the access device 12 or other implanted device can be determined with the detection of the RFID chip 70 by the reader of the ID device.
FIGURES 12A and 12B depict details with respect to a needle guide assembly 80 for use with the ID device 30, according to one embodiment. The needle guide assembly 80 includes a body 82 configured to press fit or otherwise connect to a portion of the ID device 30, such as the spacers 48 (FIGURE 12B), when used with an ID device similar to that shown in FIGURE 4A. The body 82 includes a needle guide 84 for guiding a needle 86. A dressing 88 is wound in an undeployed configuration and connected to a portion of the body 82. The needle 86 pierces the body 82 and the dressing 88. Of this In the configured form, the needle guide assembly 80 is useful for guiding the needle 86 toward the membrane of an implanted access device while using the ID device 30 to locate the device, such as by the projected image 58 of the device, as is shown in. FIGURE 12C. After the needle has been placed, the dressing 88 can be removed from the body 82, then rolled and deployed on the skin over the insertion site of the needle 86 to provide a barrier and the dressing for the site of the needle. · In-serción, as shown in FIGURE 12C. In one embodiment, the dressing includes antimicrobial properties.
FIGURE 13 shows a needle guide assembly 90 according to another embodiment, including a body 92 shaped to be held by a user and a slot defined by the body for receiving therein a needle 96. A needle guide it can be included in the slot to assist with the guiding of the guide 96. A rolled-up non-deployed pocket 98 (shown partially unrolled in FIGURE 13) is also included, the pocket is pre-drilled by the needle 96. The guide assembly 90 The needle is used to allow the needle 96 to be inserted into a patient insertion site, then to cover the skin near the insertion site with the dressing 98 without first removing the patient's needle.
Modes of the invention may be presented in other specific forms without departing from the spirit of the present disclosure. The described modalities will be considered in all respects only as illustrative, not as restrictive. The scope of the modalities is therefore indicated by the appended claims rather than by the foregoing description. All changes that fall within the meaning and scope of equivalency of the claims will be encompassed within its scope.
Claims (29)
1. An identification system for a device implanted subcutaneously in a patient, characterized in that it comprises: at least one marker included with the device, the marker can be detected by ultrasound, the marker is related to at least one predetermined attribute of the device; Y an external sensing device that includes: an ultrasound transducer to produce ultrasonic signals to crash on it. .marker of the implanted device and to detect the reflection of the ultrasonic signal by the marker; Y a screen to represent information with respect to the attribute of the implanted medical device.
2. The identification system according to claim 1, characterized in that the device includes an implantable access device and the markers are included in a body of the device.
3. The identification system according to claim 2, characterized in that the device is a catheter and the markers include a catheter body.
4. The identification system according to claim 1, characterized in that a plurality of markers is used, the markers arranged in a predetermined pattern for detection by the detection device.
5. The identification system according to claim 1, characterized in that the device includes an implantable access system and where the predetermined attribute includes at least one of a type or size of the access device, a capacity of the access device to support injection of a fluid's energy, and an implanted location of the access device.
6. An external detection device for a medical device implanted in a patient, the medical device includes at least one marker which is related to an attribute of the medical device, the. Detection device characterized because it includes: a signal source that emits an · electromagnetic signal incident to collide on the marker of the implanted device; a detector for detecting a return signal of the marker resulting from the collision of the incident electromagnetic signal; Y a user interface for transporting information with respect to the attribute based on the detection of the return signal.
7. The detection device according to claim 6, characterized in that the medical device includes an access device that can be accessed by a needle and where the user interface includes a screen to visually represent an image in relation to the attribute.
8. The detection device according to claim 6, characterized in that the incident electromagnetic signals include a first wavelength and the return signal is electromagnetic radiation that includes a second wavelength.
9. The detection device according to claim 8, characterized in that the incident and return signals include a substantially similar wavelength.
• 10. The compliance detection device according to claim 9, characterized in that the incident and return signals include infrared electromagnetic radiation.
11. The detection device according to claim 6, characterized in that the return signal is produced by at least one marker by at least one of a signal reflection and fluorescence.
12. The detection device according to claim 6, characterized in that the signal source includes an LED and where the detector includes an image capture camera.
13. An identification system by a medical device implanted in a patient, characterized in that it comprises: at least one marker included with the implanted medical device, the marker is related to an attribute of the implanted medical device; Y an external detection device that includes: a signal source that emits a signal. electromagnetic incident so that it hits the marker of the implanted medical device; a detector, which detects a return signal from the. marker. results from the collision of the incident electromagnetic signal; Y a user interface for transporting information in relation to the attribute based on the detection of the return signal.
14. The identification system according to claim 13, characterized in that the user interface includes a projector for projecting an image with respect to the medical device implanted in the skin of the patient.
15. The identification system according to claim 14, characterized in that the projected image is related to the attribute of the medical device.
16. The identification system according to claim 14, characterized in that the image is projected on the skin of the patient above the subcutaneous position of the implanted medical device to help access the medical device.
17. The identification system according to claim 16, characterized in that the projected image is a representative image of the implanted medical device.
18. The identification system according to claim 13, characterized in that - the incident electromagnetic signal and the signal of. return include ultraviolet wavelength radiation.
19 '. The detection device according to claim 13, further characterized in that it comprises: first and second spacers arranged to separate the signal source and detector from the skin surface of the patient; Y A needle guide assembly that can be removably connected to the first and second spacers, the needle guide assembly includes a rolled dressing that can be deployed to cover a needle insertion site in the patient's skin after a needle has accessed the implanted medical device.
20. An identification system for an access device implanted in a patient, characterized in that it comprises: at least one marker included with the access device, the marker is related to an attribute of the access device; Y an external detection device that includes: a signal source that emits an incident infrared electromagnetic signal so that it hits the marker of the access device; a detector that detects a return signal of the marker resulting from the collision of the incident infrared electromagnetic signal; . .-. a screen to represent information regarding the attribute based on the detection of the return signal. | '' · .-.
21. The identification system according to claim 20, further characterized in that it comprises a light protector connected to the detection device on the detector, the light protector reduces a number of foreign electromagnetic signals arriving at the detector.
22. The identification system according to claim 20, further characterized in that it comprises a projector for projecting an image relative to the medical device implanted in the skin of the patient, where the projected image is related to the attribute of the medical device, and where the marker includes a portion or totality of the access device body.
23. The identification system according to claim 20, characterized in that the marker includes at least one of a plurality of points arranged on a surface of the access device, at least one marker with bands, a marker in the form of a ring, and at least one marker included in a membrane of the access device.
24. A method for identifying a medical device implanted subcutaneously in a patient, the method characterized in that. includes: crash an incident electromagnetic signal transcutaneously. about, a "marker included with the implanted medical device, the marker is related to-an attribute of the implanted medical device; detecting a return signal resulting from the collision of the electromagnetic signal incident on the marker of the implanted medical device; Y transport information in relation to the attribute based on the detection of the return signal.
25. The method for identifying according to claim 24, characterized in that colliding the electromagnetic signal and detecting the return signal is performed by an external detection device placed close to the skin of the patient during use.
26. The method for identifying according to claim 24, characterized in that transporting the information further comprises visually representing the information on a screen included with the external detection device.
27. The method for identifying according to claim 24, characterized in that transporting the information further comprises projecting an image onto the skin of the patient to assist in locating the implanted medical device.
28. An identifiable medical device for implantation in the body of a patient, characterized in that it includes at least one marker included with the implanted medical device, the marker is related to an attribute of the implanted medical device, the marker allows the identification of the attribute by an external detection device, the marker emits a return signal when it hits an electromagnetic signal incident from the external detection device.
29. The medical device according to claim 28, characterized in that the information regarding the attribute based on the detection of the return signal is transported to a user through a user interface of the external detection device.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32501510P | 2010-04-16 | 2010-04-16 | |
PCT/US2011/032166 WO2011130310A1 (en) | 2010-04-16 | 2011-04-12 | Guerbet alcohol alkoxylate surfactants and their use in enhanced oil recovery applications |
US13/085,248 US8841241B2 (en) | 2010-04-16 | 2011-04-12 | Anionic polyalkoxy group comprising surfactants on basis of guerbet-alcohols, method of manufacture and use in enhanced oil recovery (EOR) applications |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012011796A true MX2012011796A (en) | 2013-02-07 |
Family
ID=44798996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012011796A MX2012011796A (en) | 2010-04-16 | 2011-04-12 | Guerbet alcohol alkoxylate surfactants and their use in enhanced oil recovery applications. |
Country Status (11)
Country | Link |
---|---|
US (2) | US8841241B2 (en) |
EP (2) | EP2738236B1 (en) |
CN (1) | CN103003385B (en) |
AU (1) | AU2011240606B2 (en) |
CA (1) | CA2793499C (en) |
EA (1) | EA022635B1 (en) |
EC (1) | ECSP12012240A (en) |
MX (1) | MX2012011796A (en) |
MY (1) | MY150849A (en) |
WO (1) | WO2011130310A1 (en) |
ZA (1) | ZA201207053B (en) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8596367B2 (en) | 2010-03-10 | 2013-12-03 | Basf Se | Process for producing mineral oil using surfactants based on C16C18-containing alkyl propoxy surfactants |
US8607865B2 (en) | 2010-03-10 | 2013-12-17 | Basf Se | Process for extracting mineral oil using surfactants based on butylene oxide-containing alkyl alkoxylates |
AU2011240606B2 (en) | 2010-04-16 | 2013-07-18 | Basf Se | Guerbet alcohol alkoxylate surfactants and their use in enhanced oil recovery applications |
WO2011131549A1 (en) | 2010-04-23 | 2011-10-27 | Basf Se | Method for producing mineral oil using surfactants based on a mixture of c32-guerbet-, c34-guerbet-, c36-guerbet-containing alkyl alkoxylates |
AR082740A1 (en) | 2010-08-27 | 2012-12-26 | Univ Texas | CARBOXYL ALCOXI, WATERPROOF COMPOSITION AND HYDROCARBON MATERIAL DISPOSAL |
MY165866A (en) | 2011-03-18 | 2018-05-18 | Basf Se | Method for manufacturing integrated circuit devices, optical devices, micromachines and mechanical precision devices having patterned material layers with line-space dimensions of 50 nm and less |
EP2702117A1 (en) * | 2011-04-20 | 2014-03-05 | Shell Internationale Research Maatschappij B.V. | Method and composition for enhanced hydrocarbon recovery |
US9448221B2 (en) * | 2011-05-18 | 2016-09-20 | Saudi Arabian Oil Company | Method, solvent formulation and apparatus for the measurement of the salt content in petroleum fluids |
US9422469B2 (en) * | 2013-03-15 | 2016-08-23 | Chevron U.S.A. Inc. | Mixed carbon length synthesis of primary guerbet alcohols |
US9605198B2 (en) * | 2011-09-15 | 2017-03-28 | Chevron U.S.A. Inc. | Mixed carbon length synthesis of primary Guerbet alcohols |
US20130068457A1 (en) * | 2011-09-15 | 2013-03-21 | Chevron U.S.A. Inc. | Method of Manufacture of Guerbet Alcohols For Making Surfactants Used In Petroleum Industry Operations |
EA201490776A1 (en) * | 2011-10-24 | 2014-10-30 | Басф Се | METHOD OF OIL PRODUCTION USING SURFACE-ACTIVE COMPOUNDS BASED ON С28-GUERBET-, С30-GUERBET-, С-32-GUERBET-CONTAINING HYDROGEN-ALKOXYLAT |
WO2013060623A1 (en) * | 2011-10-24 | 2013-05-02 | Basf Se | Method for producing mineral oil using surfactants based on a mixture of c20-guerbet-, c22-guerbet-, c24-guerbet-containing hydrocarbon alkoxylates |
US9475979B2 (en) * | 2011-10-24 | 2016-10-25 | Basf Se | Process for producing mineral oil using surfactants based on a mixture of C20 Guerbet-, C22 Guerbet-, C24 Guerbet-containing hydrocarbyl alkoxylates |
US9475978B2 (en) * | 2011-10-24 | 2016-10-25 | Basf Se | Process for producing mineral oil using surfactants based on a mixture of C24 guerbet-, C26 guerbet-, C28-guerbet containing hydrocarbyl alkoxylates |
US9475977B2 (en) * | 2011-10-24 | 2016-10-25 | Basf Se | Process for producing mineral oil using surfactants based on a mixture of C28 Guerbet, C30 Guerbet, C32 Guerbet-containing hydrocarbyl alkoxylates |
BR112014009825A2 (en) * | 2011-10-24 | 2017-05-02 | Basf Se | surfactant mixture, aqueous surfactant formulation, processes for producing mineral oil and preparing a surfactant mixture, and use of a surfactant mixture |
US9428432B2 (en) | 2011-11-24 | 2016-08-30 | BASF Wintershall Holding GmbH | Derivatives of tris(2-hydroxyphenyl)methanes, preparation thereof and use thereof for mineral oil production |
AR090723A1 (en) * | 2012-04-19 | 2014-12-03 | Univ Texas | SHORT HYDROPHOBE TENSIOACTIVE |
AR090958A1 (en) * | 2012-05-09 | 2014-12-17 | Shell Int Research | METHOD FOR THE IMPROVED RECOVERY OF HYDROCARBONS |
JP2015516017A (en) * | 2012-05-10 | 2015-06-04 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Alkoxylated alcohols and their use in hard surface cleaning formulations |
US20140116690A1 (en) * | 2012-10-26 | 2014-05-01 | Basf Se | Process for mineral oil production using surfactants at least comprising a secondary alkanesulfonate as a cosurfactant |
US20140174735A1 (en) * | 2012-12-26 | 2014-06-26 | Shell Oil Company | Method, system, and composition for producing oil |
CA2896311A1 (en) | 2013-01-16 | 2014-07-24 | Shell Internationale Research Maatschappij B.V. | Method, system, and composition for producing oil |
US20160068742A1 (en) * | 2013-05-29 | 2016-03-10 | Huntsman Petrochemical Llc | Use of Organic Acids or a Salt Thereof in Surfactant-Based Enhanced Oil Recovery Formulations and Techniques |
CA2915832C (en) * | 2013-06-17 | 2022-02-22 | China Petroleum & Chemical Corporation | Surfactant composition comprising a cationic quaternary ammonium surfactant and an anionic-nonionic surfactant, production and use thereof |
CN104277814B (en) * | 2013-07-09 | 2017-09-15 | 中国石油化工股份有限公司 | Surfactant oil displacement composition, preparation method and application |
GB2536395A (en) * | 2014-01-16 | 2016-09-14 | Shell Int Research | Process and composition for producing oil |
WO2015138444A1 (en) * | 2014-03-10 | 2015-09-17 | Board Of Regents, The University Of Texas System | Ammonia nh4x compositions for use with hard brine |
US9976072B2 (en) | 2014-03-26 | 2018-05-22 | Chevron U.S.A. Inc. | Multicarboxylate compositions and method of making the same |
WO2016023139A1 (en) * | 2014-08-12 | 2016-02-18 | 中国石油化工股份有限公司 | Surfactant composition and preparation method therefor and application thereof |
US20160280987A2 (en) * | 2014-08-25 | 2016-09-29 | Prochem International BV | Non-toxic and biodegradable surfactants |
US10370584B2 (en) * | 2014-09-24 | 2019-08-06 | Dow Global Technologies Llc | Method for subterranean petroleum recovery using a surfactant blend |
WO2016061712A1 (en) * | 2014-10-22 | 2016-04-28 | 中国石油化工股份有限公司 | Anionic-cationic-nonionic surfactant and manufacturing method and application thereof |
EP3233750A4 (en) * | 2014-12-16 | 2018-05-30 | Huntsman Petrochemical LLC | Ultra-high salinity surfactant formulation |
CA2976263C (en) * | 2015-02-27 | 2023-03-21 | Ecolab Usa Inc. | Compositions for enhanced oil recovery |
TW201638294A (en) * | 2015-04-30 | 2016-11-01 | 陶氏全球科技公司 | Co-surfactant foam-forming composition for enhanced oil recovery |
FR3037595B1 (en) * | 2015-06-18 | 2017-06-23 | Rhodia Operations | ETHOXYL DESORBENT AGENTS FOR ASSISTED OIL RECOVERY |
WO2017196938A1 (en) | 2016-05-13 | 2017-11-16 | Ecolab USA, Inc. | Corrosion inhibitor compositions and methods of using same |
US11203709B2 (en) | 2016-06-28 | 2021-12-21 | Championx Usa Inc. | Compositions for enhanced oil recovery |
CN106701051B (en) * | 2016-12-23 | 2019-12-03 | 卫辉市化工有限公司 | A kind of well cementation preparation method of oil-base mud irrigation and flushing liquor |
BR112020005885A2 (en) | 2017-09-26 | 2020-09-29 | Ecolab Usa Inc. | antimicrobial, virucide, solid antimicrobial and solid virucide compositions, and methods for using an antimicrobial composition and inactivating a virus. |
US11434416B2 (en) * | 2018-04-19 | 2022-09-06 | ExxonMobil Technology and Engineering Company | Formation of in-situ activated injection fluids for enhanced oil recovery applications |
US20200010757A1 (en) * | 2018-07-05 | 2020-01-09 | Baker Hughes, A Ge Company, Llc | Formulation to increase oil recovery |
CN109504549B (en) * | 2018-09-26 | 2021-03-16 | 武汉奥克特种化学有限公司 | Preparation and application of environment-friendly low-foam alkali-resistant solubilizer |
AR118833A1 (en) * | 2019-05-03 | 2021-11-03 | Sasol Performance Chemicals Gmbh | NON-AQUEOUS DEFOAMING COMPOSITIONS AND THEIR USE IN FOAM CONTROL OF NON-AQUEOUS FOAMS |
JPWO2020241779A1 (en) * | 2019-05-28 | 2020-12-03 | ||
US11725143B2 (en) | 2019-05-28 | 2023-08-15 | Kao Corporation | Rust inhibitor, rust inhibitor composition, coating formation material, coating, and metal component |
WO2020241787A1 (en) | 2019-05-28 | 2020-12-03 | 花王株式会社 | Oil agent additive and oil agent composition |
EP3978106B1 (en) | 2019-05-28 | 2024-01-31 | Kao Corporation | Surfactant and surfactant composition |
CN112795002B (en) | 2019-11-14 | 2022-04-01 | 中国石油化工股份有限公司 | Polyether anionic and nonionic surfactant containing heteroatom and preparation method thereof |
CN112791662A (en) * | 2019-11-14 | 2021-05-14 | 中国石油化工股份有限公司 | Alkoxy polyether anionic and nonionic surfactant and preparation method thereof |
US20230097814A1 (en) * | 2020-01-23 | 2023-03-30 | Chevron U.S.A. Inc. | Compositions and methods for the recovery of oil under harsh conditions |
US11649395B2 (en) * | 2020-03-20 | 2023-05-16 | Cnpc Usa Corporation | Nonionic surfactants employed with extended chain as the oil displacement agent to use in enhanced oil recovery |
CN113801316B (en) * | 2020-06-15 | 2024-01-26 | 中国石油化工股份有限公司 | Alkoxy block polyether sulfonate anionic surfactant and preparation method thereof |
RU2764968C1 (en) * | 2020-09-10 | 2022-01-24 | Общество с ограниченной ответственностью ООО "САНСОРС МИНЕРАЛС" | Composition and method for processing petroleum formations |
CN114456370B (en) * | 2020-11-10 | 2024-01-26 | 中国石油化工股份有限公司 | Polyether anionic surfactant and method for improving oil and gas recovery ratio |
US11530348B2 (en) | 2021-03-15 | 2022-12-20 | Saudi Arabian Oil Company | Ionic liquid enhanced surfactant solution for spontaneous imbibition in fractured carbonate reservoirs |
WO2023028376A1 (en) * | 2021-08-27 | 2023-03-02 | Ultimate Eor Services Llc | Ultra-short hydrophobe alkoxylates as surfactants |
US11873446B2 (en) | 2021-09-28 | 2024-01-16 | Third Wave Production, LLC | Injection of nonionic surfactants into wells for increased oil production |
WO2023064364A1 (en) * | 2021-10-12 | 2023-04-20 | Huntsman Petrochemical Llc | Method of producing alkoxylated ether amines and uses thereof |
FR3133610A1 (en) * | 2022-03-18 | 2023-09-22 | Coatex | THICKENING ALKYL COPOLYMER |
CN114790384B (en) * | 2022-05-31 | 2023-02-03 | 中国石油大学(北京) | Micromolecule imbibition agent and preparation method and application thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0167337A2 (en) * | 1984-06-25 | 1986-01-08 | Atlantic Richfield Company | Alkoxylated ether sulfate anionic surfactants |
DE3735056A1 (en) | 1987-10-16 | 1989-04-27 | Basf Ag | METHOD FOR THE PRODUCTION OF ETHER AND POLYGLYKOLETHERSULFONATES AND PRODUCTS PRODUCED BY THIS METHOD |
US5092405A (en) | 1990-12-21 | 1992-03-03 | Texaco Inc. | Alkoxylated surfactant system for heavy oil reservoirs |
DE4325237A1 (en) | 1993-07-28 | 1995-02-02 | Basf Ag | Process for the preparation of alkoxylation products in the presence of mixed hydroxides modified with additives |
EP1022326A1 (en) * | 1999-01-20 | 2000-07-26 | The Procter & Gamble Company | Hard surface cleaning compositions comprising modified alkylbenzene sulfonates |
EP1022325A3 (en) * | 1999-01-20 | 2003-01-02 | The Procter & Gamble Company | Hard surface cleaning compositions comprising modified alkylbenzene sulfonates |
WO2000043476A2 (en) | 1999-01-20 | 2000-07-27 | The Procter & Gamble Company | Dishwashing detergent compositions containing mixtures of crystallinity-disrupted surfactants |
DE10243361A1 (en) | 2002-09-18 | 2004-04-01 | Basf Ag | Alkoxylate mixture used in laundry and cleaning detergents for washing and cleaning textiles contains alkoxylates of alkanols with different chain lengths with ethylene oxide and optionally other alkylene oxide(s) |
DE10244361A1 (en) | 2002-09-24 | 2004-04-01 | Daimlerchrysler Ag | Device for vibration damping in a vehicle |
JPWO2005022660A1 (en) | 2003-08-29 | 2006-10-26 | 松下電器産業株式会社 | Organic semiconductor film, electronic device using the same, and manufacturing method thereof |
US7119125B1 (en) * | 2003-09-26 | 2006-10-10 | O'lenick Jr Anthony J | Bi-modal Guerbet alkoxy sulfate surfactants |
DE102005026716A1 (en) | 2005-06-09 | 2006-12-28 | Basf Ag | Surfactant mixtures for tertiary mineral oil production |
CA2594108C (en) | 2007-03-09 | 2014-06-03 | Techstar Energy Services Inc. | Drilling fluid and methods |
US7985718B2 (en) | 2008-04-21 | 2011-07-26 | Basf Se | Use of surfactant mixtures for tertiary mineral oil extraction |
MX2010004526A (en) * | 2009-04-30 | 2010-11-01 | Basf Se | Dispersing agent. |
WO2011037975A2 (en) | 2009-09-22 | 2011-03-31 | Board Of Regents, The University Of Texas System | Method of manufacture and use of large hydrophobe ether sulfate surfactants in enhanced oil recovery (eor) applications |
US8607865B2 (en) | 2010-03-10 | 2013-12-17 | Basf Se | Process for extracting mineral oil using surfactants based on butylene oxide-containing alkyl alkoxylates |
US8596367B2 (en) | 2010-03-10 | 2013-12-03 | Basf Se | Process for producing mineral oil using surfactants based on C16C18-containing alkyl propoxy surfactants |
US20110220364A1 (en) | 2010-03-10 | 2011-09-15 | Basf Se | Process for mineral oil production using cationic surfactants having a hydrophobic block with a chain length of 6 to 10 carbon atoms |
EA023089B1 (en) | 2010-03-10 | 2016-04-29 | Басф Се | Use of surfactant mixtures of polycarboxylates for microemulsion flooding |
AU2011240606B2 (en) | 2010-04-16 | 2013-07-18 | Basf Se | Guerbet alcohol alkoxylate surfactants and their use in enhanced oil recovery applications |
-
2011
- 2011-04-12 AU AU2011240606A patent/AU2011240606B2/en not_active Ceased
- 2011-04-12 CA CA2793499A patent/CA2793499C/en not_active Expired - Fee Related
- 2011-04-12 EP EP13199022.8A patent/EP2738236B1/en not_active Not-in-force
- 2011-04-12 EA EA201270743A patent/EA022635B1/en not_active IP Right Cessation
- 2011-04-12 MY MYPI2012004060 patent/MY150849A/en unknown
- 2011-04-12 CN CN201180019219.0A patent/CN103003385B/en not_active Expired - Fee Related
- 2011-04-12 US US13/085,248 patent/US8841241B2/en not_active Expired - Fee Related
- 2011-04-12 MX MX2012011796A patent/MX2012011796A/en active IP Right Grant
- 2011-04-12 EP EP11769466.1A patent/EP2558546A4/en not_active Withdrawn
- 2011-04-12 WO PCT/US2011/032166 patent/WO2011130310A1/en active Application Filing
-
2012
- 2012-09-19 ZA ZA2012/07053A patent/ZA201207053B/en unknown
- 2012-10-09 EC ECSP12012240 patent/ECSP12012240A/en unknown
-
2014
- 2014-03-07 US US14/201,323 patent/US9296942B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20140182851A1 (en) | 2014-07-03 |
EP2738236A1 (en) | 2014-06-04 |
EP2558546A4 (en) | 2013-09-18 |
ECSP12012240A (en) | 2012-11-30 |
US9296942B2 (en) | 2016-03-29 |
EP2558546A1 (en) | 2013-02-20 |
AU2011240606A1 (en) | 2012-09-27 |
ZA201207053B (en) | 2013-05-29 |
US8841241B2 (en) | 2014-09-23 |
WO2011130310A1 (en) | 2011-10-20 |
MY150849A (en) | 2014-03-14 |
CA2793499A1 (en) | 2011-10-20 |
EP2738236B1 (en) | 2016-04-06 |
CA2793499C (en) | 2014-12-30 |
CN103003385B (en) | 2015-06-03 |
CN103003385A (en) | 2013-03-27 |
EA201270743A1 (en) | 2013-02-28 |
US20110281779A1 (en) | 2011-11-17 |
EA022635B1 (en) | 2016-02-29 |
AU2011240606B2 (en) | 2013-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012011796A (en) | Guerbet alcohol alkoxylate surfactants and their use in enhanced oil recovery applications. | |
US10471205B2 (en) | Systems and methods for identifying and locating an implanted device | |
US9861296B2 (en) | Ingestible probe with agent delivery | |
US20080138289A1 (en) | Systems and methods for detecting infrared emitting composites and medical applications therefor | |
US8812368B1 (en) | Computerized information collection and processing apparatus | |
US20150196369A1 (en) | System, method and device employing fiducials for medical intervention | |
US8187189B2 (en) | Imaging via blood vessels | |
US8068897B1 (en) | Endoscopic smart probe and method | |
US7914442B1 (en) | Endoscopic smart probe and method | |
CN108136107A (en) | Syringe fluid filling verification and the system and method for the image identification of powered injector systems feature | |
US20100099982A1 (en) | System, Device, and Method for Determining a Position of an Object | |
CN104080400A (en) | System for imaging lesions aligning tissue surfaces | |
JP6929294B2 (en) | Embeddable markers, devices and methods for using them | |
US20140005542A1 (en) | Target region identification for imaging applications | |
US20120172711A1 (en) | Injectable Vascular Access Port with Discernable Markers for Identification | |
CN101836873A (en) | Biopsy device | |
EP1561420A3 (en) | Lesion identification system for surgical operation and related method | |
WO2009144653A2 (en) | Needle with integrated photon detector | |
CN107106253B (en) | Pulsating light-emitting marking device | |
JP6810950B2 (en) | RF tag markers, luminescence markers and their detectors | |
JP2018538015A (en) | Signal tag detection element, apparatus and system | |
CN112656370A (en) | Parathyroid gland position detecting instrument | |
JP2021532849A (en) | Device for locating medical implants | |
CN215272682U (en) | Parathyroid gland position detecting instrument | |
US20190008604A1 (en) | System and method for marking and subsequently locating sites of biopsies using rfid technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |